Patent · US Active

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

US9453013B2 · kind B2 · utility

0Cited by

3References

16Claims

0Family size

Assignee

Chiesi Farmaceutici S.p.A. · IT

Inventors

Fabio Rancati · Parma, IT
Ian Linney · London, GB
Chris Knight · Ottawa, CA
Wolfgang Schmidt · Frankfurt, DE

Key dates

Filing date	Jan 30, 2015
Grant date	Sep 27, 2016
Priority date	—
Expiry date	Jan 30, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) defined herein act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for the prevention and/or treatment of broncho-obstructive or inflammatory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.